A detailed history of Rhumbline Advisers transactions in Masimo Corp stock. As of the latest transaction made, Rhumbline Advisers holds 127,014 shares of MASI stock, worth $21.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
127,014
Previous 127,773 0.59%
Holding current value
$21.9 Million
Previous $16.1 Million 5.2%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$104.79 - $133.77 $79,535 - $101,531
-759 Reduced 0.59%
127,014 $16.9 Million
Q2 2024

Aug 01, 2024

SELL
$115.24 - $144.91 $617,571 - $776,572
-5,359 Reduced 4.03%
127,773 $16.1 Million
Q1 2024

May 09, 2024

SELL
$109.17 - $146.85 $526,090 - $707,670
-4,819 Reduced 3.49%
133,132 $19.6 Million
Q4 2023

Feb 08, 2024

SELL
$76.73 - $120.62 $351,269 - $552,198
-4,578 Reduced 3.21%
137,951 $16.2 Million
Q3 2023

Nov 09, 2023

SELL
$84.17 - $161.17 $1.39 Million - $2.65 Million
-16,455 Reduced 10.35%
142,529 $12.5 Million
Q2 2023

Aug 08, 2023

BUY
$155.24 - $196.47 $1.49 Million - $1.89 Million
9,627 Added 6.45%
158,984 $26.2 Million
Q1 2023

May 11, 2023

BUY
$146.03 - $184.54 $345,506 - $436,621
2,366 Added 1.61%
149,357 $27.6 Million
Q4 2022

Feb 14, 2023

BUY
$110.88 - $150.36 $688,121 - $933,134
6,206 Added 4.41%
146,991 $21.7 Million
Q3 2022

Nov 10, 2022

SELL
$125.58 - $169.38 $376,488 - $507,801
-2,998 Reduced 2.09%
140,785 $19.9 Million
Q2 2022

Aug 11, 2022

BUY
$112.97 - $151.71 $881,391 - $1.18 Million
7,802 Added 5.74%
143,783 $18.8 Million
Q1 2022

May 12, 2022

BUY
$135.71 - $284.87 $119,289 - $250,400
879 Added 0.65%
135,981 $19.8 Million
Q4 2021

Feb 10, 2022

BUY
$266.41 - $303.29 $659,631 - $750,946
2,476 Added 1.87%
135,102 $39.6 Million
Q3 2021

Nov 12, 2021

SELL
$249.0 - $285.24 $601,833 - $689,425
-2,417 Reduced 1.79%
132,626 $35.9 Million
Q2 2021

Aug 05, 2021

BUY
$208.49 - $248.2 $247,060 - $294,117
1,185 Added 0.89%
135,043 $32.7 Million
Q1 2021

May 06, 2021

SELL
$220.31 - $283.75 $858,327 - $1.11 Million
-3,896 Reduced 2.83%
133,858 $30.7 Million
Q4 2020

Feb 10, 2021

SELL
$223.82 - $271.35 $771,955 - $935,886
-3,449 Reduced 2.44%
137,754 $37 Million
Q3 2020

Nov 12, 2020

SELL
$209.49 - $246.81 $877,134 - $1.03 Million
-4,187 Reduced 2.88%
141,203 $33.3 Million
Q2 2020

Aug 13, 2020

BUY
$178.49 - $250.39 $2.63 Million - $3.69 Million
14,737 Added 11.28%
145,390 $33.1 Million
Q1 2020

May 06, 2020

SELL
$148.38 - $186.78 $151,199 - $190,328
-1,019 Reduced 0.77%
130,653 $23.1 Million
Q4 2019

Feb 05, 2020

SELL
$140.81 - $159.49 $139,542 - $158,054
-991 Reduced 0.75%
131,672 $20.8 Million
Q3 2019

Oct 23, 2019

SELL
$145.61 - $159.87 $316,701 - $347,717
-2,175 Reduced 1.61%
132,663 $19.7 Million
Q2 2019

Aug 14, 2019

BUY
$122.29 - $148.82 $194,930 - $237,219
1,594 Added 1.2%
134,838 $20.1 Million
Q1 2019

May 01, 2019

BUY
$102.78 - $138.28 $179,248 - $241,160
1,744 Added 1.33%
133,244 $18.4 Million
Q4 2018

Jan 31, 2019

BUY
$98.38 - $125.32 $3.63 Million - $4.63 Million
36,927 Added 39.05%
131,500 $14.1 Million
Q3 2018

Nov 07, 2018

SELL
$97.19 - $124.54 $188,548 - $241,607
-1,940 Reduced 2.01%
94,573 $11.8 Million
Q2 2018

Aug 06, 2018

BUY
$83.88 - $102.21 $381,989 - $465,464
4,554 Added 4.95%
96,513 $9.42 Million
Q1 2018

May 02, 2018

SELL
$82.06 - $95.19 $549,227 - $637,106
-6,693 Reduced 6.78%
91,959 $8.09 Million
Q4 2017

Feb 09, 2018

SELL
$84.49 - $90.09 $750,102 - $799,819
-8,878 Reduced 8.26%
98,652 $8.37 Million
Q3 2017

Nov 06, 2017

BUY
$81.79 - $96.62 $8.79 Million - $10.4 Million
107,530
107,530 $9.31 Million

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $9.05B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.